MapLight Therapeutics' Vishwas Setia Separated As CFO Effective Immediately; Jonathan Gillis Appointed As Interim CFO Effective June 18, 2026

MapLight Therapeutics, Inc.

MapLight Therapeutics, Inc.

MPLT

0.00

-SEC Filing